On September 23, 2024, Outset Medical was notified by Nasdaq that its stock price fell below $1.00 for 30 consecutive days, risking delisting, but it regained compliance by December 24, 2024, and received another notice of non-compliance on February 24, 2025, with a new compliance period until August 25, 2025.